Tenderfy

Gene testing and reporting for Ovarian cancer specimens

Buyer
NHS Greater Glasgow and Clyde
Published
2026-11-19
Deadline
Not provided
Sources
UK_FTS
Value
Not provided

Description

The description is in the source language.

NHS Greater Glasgow and Clyde, Laboratory Genetics requires an end-to-end diagnostic service for FFPE block processing, DNA based Homologous Repair Deficiency (HRD) and BRCA1 and BRCA2 gene testing and reporting for Ovarian cancer specimens. This service is required for approximately 200 tests per annum and the service must be available by 1st December 2026.

CPV: 85145000

Membership

Read notice previews free of charge. Official notice and document links, construction permits and personal MCP access require an active paid membership.

Read